ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,541Medicare Part D Prescriptions Filled, Including Refills

Rank: 46 out of 783

$1.14M Total Retail Price of All Prescriptions

Rank: 31 out of 783

725 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 725 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

23% of this provider’s 725 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 14,351 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 887 673 S3 1 2
LEVOTHYROXINE SODIUM 552 495 2 1
OMEPRAZOLE 452 373 3 6
SIMVASTATIN 436 392 4 3
LISINOPRIL 353 305 5 4
WARFARIN SODIUM 321 273 6 10
GABAPENTIN 306 210 7 15
FUROSEMIDE 306 267 7 7
ATENOLOL 305 285 9 17
METOPROLOL TARTRATE 265 250 10 9
ZOLPIDEM TARTRATE 253 190 11 23
DONEPEZIL HCL 233 219 12 24
CITALOPRAM HBR 230 189 13 19
LOSARTAN POTASSIUM 229 206 14 18
METFORMIN HCL 226 193 15 8
CARVEDILOL 209 191 16 21
AMLODIPINE BESYLATE 207 177 17 5
BUMETANIDE 207 182 17 131
PRAVASTATIN SODIUM 199 166 19 14
POTASSIUM CHLORIDE 197 181 20 16
SPIRONOLACTONE 193 174 21 57
CIPROFLOXACIN HCL 190 162 22 62
AZITHROMYCIN 186 169 23 41
GLIMEPIRIDE 179 164 24 34
LANTUS 178 153 25 38
HYDROCHLOROTHIAZIDE 178 167 25 12
METOPROLOL SUCCINATE 175 146 27 13
PROMETHAZINE HCL 167 92 R 28 97
NAMENDA 162 162 29 32
TRAMADOL HCL 159 115 30 20
ALLOPURINOL 157 146 31 31
CLONIDINE HCL 154 137 32 60
METFORMIN HCL ER 152 132 33 64
PAROXETINE HCL 145 110 34 69
AMOXICILLIN 132 98 35 116
ATORVASTATIN CALCIUM 131 111 36 11
CYMBALTA 121 80 37 35
POLYETHYLENE GLYCOL 3350 121 118 37 43
BACLOFEN 117 45 39 125
FLUOXETINE HCL 116 70 40 45
FAMOTIDINE 113 71 41 55
PREDNISONE 110 97 42 36
RISPERIDONE 109 95 43 67
BISOPROLOL-HYDROCHLOROTHIAZIDE 102 88 44 154
MIRTAZAPINE 101 100 45 52
DOXAZOSIN MESYLATE 97 88 46 87
DICLOFENAC SODIUM 96 79 47 139
DIVALPROEX SODIUM 96 75 47 72
TRAZODONE HCL 91 47 49 39
KLOR-CON 10 90 89 50 102
CLOPIDOGREL 90 78 50 29
CEPHALEXIN 85 75 52 70
TAMSULOSIN HCL 85 82 52 26
FLUTICASONE PROPIONATE 82 66 54 46
ALENDRONATE SODIUM 81 76 55 25
ENALAPRIL MALEATE 79 62 56 68
IBUPROFEN 78 37 57 115
SPIRIVA 77 67 58 59
DILTIAZEM ER 73 73 59 153
ADVAIR DISKUS 71 59 60 50
OXYBUTYNIN CHLORIDE 71 71 60 96
PEN NEEDLE 70 54 62 103
PROAIR HFA 68 41 63 56
ISOSORBIDE MONONITRATE ER 68 68 63 40
LEVEMIR FLEXPEN 66 51 65 155
FENTANYL 66 64 S2 65 65
NEXIUM 66 49 65 28
DIPHENOXYLATE-ATROPINE 66 52 65 266
DOXYCYCLINE HYCLATE 64 51 69 112
LANTUS SOLOSTAR 64 51 69 91
MORPHINE SULFATE ER 63 31 S2 71 107
SULFAMETHOXAZOLE-TRIMETHOPRIM 63 46 71 95
SINGULAIR 62 33 73 90
NYSTOP 61 46 74 231
OXYCODONE-ACETAMINOPHEN 60 39 S2 75 76
KETOCONAZOLE 60 25 75 211
TIZANIDINE HCL 59 31 77 133
CYCLOBENZAPRINE HCL 59 31 R 77 63
SERTRALINE HCL 57 21 79 22
NYSTATIN 56 52 80 106
FLUCONAZOLE 56 23 80 179
DILTIAZEM 24HR ER 55 39 82 122
NOVOLOG 54 36 83 81
DILTIAZEM 24HR CD 54 54 83 118
PLAVIX 53 46 85 51
TOPIRAMATE 53 32 85 152
MELOXICAM 53 44 85 37
QUETIAPINE FUMARATE 52 40 88 79
MINOXIDIL 52 45 88 362
LANSOPRAZOLE 52 30 88 177
NITROSTAT 50 46 91 191
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 30, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.